adenovirus
virus
reli
glycan
protein
interact
attach
enter
suscept
host
cell
adenovirida
famili
compris
human
type
differ
attach
factor
receptor
usag
like
contribut
divers
tropism
differ
type
past
year
method
systemat
identifi
glycan
protein
interact
advanc
particular
sensit
speed
coverag
mass
spectrometr
analys
allow
highthroughput
identif
glycan
peptid
separ
liquid
chromatographi
also
develop
glycan
microarray
technolog
led
target
highthroughput
screen
identif
glycanbas
receptor
map
cell
surfac
interact
divers
adenoviru
type
implic
cell
tissu
speci
tropism
well
drug
develop
review
known
adenoviru
interact
glycanand
proteinbas
receptor
well
glycom
proteom
strategi
identifi
yet
elus
viru
receptor
attach
factor
final
discuss
challeng
bottleneck
futur
research
direct
field
nonenvelop
viru
entri
host
cell
viru
infect
host
cell
case
initi
one
specif
interact
capsid
protein
nonenvelop
virus
glycoprotein
envelop
virus
host
cell
receptorscoreceptor
addit
lipid
phosphatidylserin
embed
viral
envelop
interact
cell
surfac
receptor
process
term
apoptot
mimicri
review
ref
knowledg
molecul
interact
one
hand
import
understand
viru
life
cycl
tissu
tropism
speci
tropism
pathogenesi
hand
pave
way
toward
develop
antivir
drug
interfer
viru
bind
entri
cell
toward
gener
deliveri
viral
genom
intracellular
site
replic
specif
overcom
cellular
barrier
lipid
bilay
underli
cortic
actin
critic
replic
virus
oblig
intracellular
parasit
contrast
attach
factor
receptor
therefor
mediat
cell
attach
also
dictat
uptak
virion
cell
includ
intracellular
traffick
incom
virion
ultimatelyeith
directli
plasma
membran
intracellular
vesiclesth
penetr
cytosol
virus
replic
nucleu
capsid
need
addit
traffic
nuclear
pore
gener
entri
process
must
solv
assemblydisassembl
paradox
viru
particl
highli
stabl
extracellular
milieu
must
disassembl
correct
intracellular
site
therefor
virus
resid
metast
state
sensit
cellular
trigger
mechan
receptor
interact
ph
drop
chang
redox
state
ion
concentr
proteolyt
process
viral
surfac
protein
cellular
proteas
one
combin
trigger
factor
expos
membraneperturb
protein
protein
domain
lead
penetr
cytosol
famili
adenovirida
contain
differ
human
type
divid
seven
speci
ag
fig
isol
secret
stool
bronchoalveolar
lavag
tear
fluid
surgic
remov
tissu
adenoid
tonsil
thu
human
adenovirus
hadv
display
wide
cell
tissu
tropism
result
infect
eye
airway
gastrointestin
tract
lymphoid
tissu
urinari
tract
andor
liver
immunocomprom
patient
virus
caus
sever
even
lethal
system
infect
adenovirida
furthermor
interest
specif
type
associ
obes
final
frequent
serv
viral
vector
vitro
vivo
refer
reader
elsewher
detail
discuss
adenovirusbas
gene
therapi
vector
thu
hadv
clinic
relev
also
serv
templat
illustr
divers
complex
challeng
face
scientist
studi
virusreceptor
interact
anim
model
syrian
hamster
model
develop
studi
speci
c
adv
infect
howev
adv
receptor
studi
base
cell
cultur
model
linear
doublestrand
dna
genom
adv
surround
icosahedr
capsid
diamet
contain
three
major
capsid
protein
hexon
penton
base
fiber
least
eight
core
cement
protein
hexon
protein
largest
ca
kda
abund
trimer
capsom
interact
pentamer
coreceptorbind
penton
base
corner
trimer
fiber
protrud
fiber
length
vari
significantli
seven
speci
termin
receptorbind
fiber
knob
domain
fig
accord
length
longshaft
fiber
lsf
shortshaft
fiber
ssf
influenc
interact
receptor
adv
carri
lsf
ssf
contain
differ
knob
see
box
member
adenovirida
famili
virus
use
either
glycan
proteinac
receptor
combin
infect
host
cell
addit
also
bind
secretori
extracellular
molecul
coagul
factor
lactoferrin
engag
primari
receptor
adv
type
enter
cell
clathrinand
dynamindepend
endocytosi
often
involv
integrin
macropinocytosi
endocyt
compart
membran
lytic
adv
cement
protein
vi
penetr
endosom
membran
therebi
induc
endosom
escap
exposur
cement
protein
vi
resid
underneath
capsid
wall
prior
cell
attach
cell
type
induc
drift
repres
hadv
speci
g
respect
hadv
fk
sequenc
obtain
ncbi
phylogenet
tree
gener
use
phylogenyfr
http
wwwphylogenyfrindexcgi
motion
adv
receptor
interestingli
effici
adv
endocytosi
endosom
membran
pierc
requir
cellular
lipid
signal
membran
repair
mechan
viru
trigger
cell
attach
epitheliallik
cell
escap
adv
endosom
occur
rapidli
min
surfac
bind
thought
associ
drop
endosom
ph
howev
recent
data
suggest
escap
may
ph
independ
cytoplasm
adv
transport
nucleu
along
microtubul
final
nuclear
pore
disassembl
alreadi
partial
disassembl
particl
shuttl
adv
dna
nucleu
review
primarili
discuss
earli
advhost
cell
interact
well
approach
identifi
host
determin
adv
attach
earli
entri
interact
cellular
glycan
alon
rare
suffici
entri
product
infect
mostli
follow
interact
proteinac
receptor
howev
mani
case
virusglycan
interact
requir
concentr
virus
cell
surfac
bring
contact
proteinac
receptor
case
glycanbas
attach
factor
proteinac
receptor
need
infect
commonli
use
glycosyl
attach
factor
includ
sacontain
glycan
gag
hbga
sacontain
glycan
use
attach
factor
human
virus
famili
influenza
virus
iav
best
studi
sa
differ
monosaccharid
built
ninecarbon
backbon
instead
common
five
six
carbon
usual
occupi
nonreduc
end
glycan
chain
typic
link
galactos
unit
via
bond
altern
link
neighbor
sa
via
bond
via
glycan
chain
sa
conjug
lipid
protein
via
serin
threonin
olinkag
aspargin
sequon
asnxserthr
nlinkag
acid
usual
depict
prototyp
sa
abund
sa
human
differ
type
sa
identifi
natur
differ
sa
type
modifi
mainli
acetyl
glycolyl
group
also
sulfat
phosphoryl
affect
affin
viral
ligand
thu
also
cell
tissu
host
specif
virus
virus
well
studi
respect
sacontain
receptor
includ
reoviru
polyomaviru
paramyxoviru
adenoviru
small
subset
speci
hadv
type
repres
pronounc
ocular
tropism
use
sacontain
receptor
adhes
entri
human
corneal
epitheli
cell
fig
case
receptor
identif
guid
simpli
calcul
unusu
high
isoelectr
point
fiber
knob
hypothesi
receptor
would
featur
neg
charg
sacleav
neuraminidas
sablock
lectin
solubl
glycan
use
valid
sa
receptor
human
corneal
epithelium
cell
bind
infect
xray
crystallographi
analysi
fiber
knob
complex
select
sacontain
glycan
reveal
three
sabind
site
top
knob
highli
posit
charg
caviti
precis
carboxyl
acid
group
sa
interact
posit
charg
lysin
knob
caviti
subsequ
glycan
array
analysi
point
prefer
glycan
correspond
sacontain
gangliosid
gangliosid
carri
hexasaccharid
branch
two
arm
termin
sa
link
via
glycosid
bond
neighbor
galactos
unit
structur
analysi
reveal
context
sa
bind
canon
sabind
site
surfac
plasmon
reson
analysi
interact
reveal
affin
higher
level
mani
virus
typic
bind
sa
low
nm
affin
strikingli
gangliosid
use
receptor
instead
knob
use
sacontain
glycoprotein
reveal
cellbas
assay
use
exampl
metabol
inhibitor
gangliosid
biosynthesi
specif
enzym
combin
abund
sa
secret
contribut
lubric
also
barrier
pathogen
ocular
tropism
result
suggest
sacontain
definit
abbrevi
adenoviru
entri
proteom
glycom
viral
attach
protein
vap
viral
surfac
protein
bind
cellular
receptor
vap
nonenvelop
virus
adenovirus
viral
capsid
protein
penton
base
fiber
attach
factor
enabl
viru
attach
host
cell
usual
suffici
entri
infect
receptor
enabl
attach
entri
virus
host
cell
entri
factor
mediat
attach
need
entryinfect
coauxiliari
receptor
facilit
attachmententri
essenti
infect
hexon
main
capsom
adenoviru
two
hundr
forti
trimer
constitut
main
surfac
area
adenoviru
penton
base
adenoviru
capsid
compon
particl
contain
pentamer
protein
anchor
fiber
protein
capsid
need
entri
endosom
releas
attach
fiber
protein
protrud
corner
icosahedr
capsid
bind
receptor
termin
knob
domain
length
fiber
vari
significantli
adenoviru
speci
mass
spectrometri
ms
spectrometr
method
use
determin
molecular
weight
organ
compound
proteinderiv
peptid
ms
base
specif
mass
charg
given
analyt
determin
trap
dynam
electr
field
proteom
largescal
analysi
sum
protein
biolog
sampl
term
coin
often
term
specif
use
msbase
analysi
protein
glycom
largescal
analysi
glycom
complet
repertoir
glycan
glycoconjug
cell
tissu
biolog
sampl
jam
junction
adhes
molecul
jam
belong
immunoglobulin
superfamili
famili
jam
protein
compris
three
classic
famili
member
four
nonclass
member
jam
express
tight
junction
epitheli
endotheli
cell
surfac
leukocyt
platelet
erythrocyt
car
coxsacki
adenoviru
receptor
nonclass
jam
serv
receptor
coxsackievirus
adenovirus
compound
may
use
topic
treatment
ocular
hadv
infect
inde
two
type
compound
develop
evalu
vitro
first
type
compris
larger
proteinor
lipidbas
compound
capac
aggreg
progeni
therebi
limit
number
infecti
unit
eye
type
smaller
trival
compound
sa
design
fit
three
sabind
site
knob
latter
molecul
aggreg
virion
bind
virion
highaffin
block
viru
attach
therebi
prevent
infect
low
concentr
ie
concentr
reduc
infect
rate
control
low
nm
rang
anoth
adv
also
bind
sa
associ
gastroenter
human
equip
two
differ
fiber
ssf
lsf
ssf
bind
polysial
acidcontain
glycan
differ
pocket
knob
addit
sever
nonhuman
adv
type
also
bind
sacontain
glycan
gag
linear
polysaccharid
disaccharid
unit
contain
nmodifi
glucosamin
galactosamin
uron
acid
galactos
gag
substanti
longer
polym
chain
glycan
monosaccharid
sulfat
andor
n
posit
contribut
neg
charg
addit
carboxyl
acid
group
uron
acid
organ
modif
disaccharid
unit
determin
gag
type
heparan
sulfat
hs
chondroitin
sulfat
keratan
sulfat
hs
common
gagcontain
attach
factor
use
exampl
herpesvirus
flavivirus
parvovirus
papillomavirus
hiv
multipl
hepat
virus
bunyavirus
adv
type
member
speci
b
hadv
infect
eye
respiratori
andor
urinari
tract
use
gag
lowaffin
cellular
attach
factor
addit
proteinac
receptor
see
proteom
glycan
arraybas
approach
point
hs
proteoglycan
hspg
candid
attach
factor
valid
cellular
assay
use
enzymat
degrad
gagdefici
cell
strike
conclus
two
independ
mechan
interact
hspg
exist
wherea
bind
convent
mechan
hspg
via
fiber
knob
bind
hspg
independ
knob
rel
import
mechan
gag
interact
yet
character
detail
speci
c
also
suggest
use
hs
cellular
receptor
studi
viral
gagbind
protein
identifi
howev
shaft
domain
fiber
contain
put
hsbind
domain
point
mutat
domain
alter
gene
transfer
hs
also
influenc
hadvbas
gene
transfer
indirectli
sinc
mani
hadv
bind
via
hexon
blood
factor
turn
mediat
bind
gene
transfer
hepatocyt
via
hs
gener
hs
usag
may
consequ
cell
cultur
adapt
virus
cell
line
typic
express
high
level
hs
thu
hs
depend
need
analyz
cautious
includ
test
primari
viru
isol
hs
depend
vivo
hbga
base
precursor
disaccharid
contain
gal
galnac
glc
glcnac
link
differ
type
glycosid
bond
precursor
decor
addit
monosaccharid
includ
fucos
sa
result
chain
commonli
contain
three
five
monosaccharid
antigen
express
multipl
protein
cell
secret
wellcharacter
receptor
gastrointestin
caliciviru
rotaviru
glycosphingolipid
gsl
glycosyl
lipid
present
outer
leaflet
plasma
membran
glycan
chain
face
extracellular
space
contain
seven
monosaccharid
unit
includ
hbga
sa
sacontain
gsl
also
refer
gangliosid
latter
associ
cholesterol
rich
membran
microdomain
gener
gsl
enrich
apic
side
polar
cell
contribut
exampl
endocytosi
sinc
sa
hbga
build
block
molecul
virus
iav
rotavirus
calicivirus
also
polyomavirus
parvovirus
other
use
gsl
receptor
interestingli
mani
envelop
virus
attach
cell
use
glycosyl
molecul
viru
surfac
therebi
flip
coin
specif
virus
use
transmembran
viral
spike
glycosyl
viral
host
cellencod
glycosyltransferas
result
escap
neutral
antibodi
also
allow
bind
host
cell
lectin
extend
viral
tropism
consequ
exampl
lectin
ctype
lectin
dcsign
express
dendrit
cell
contribut
cellcel
adhes
dcsign
ctype
lectin
bind
mannosecontain
glycan
commonli
decor
viral
spike
sever
virus
report
interact
ctype
lectin
clear
role
cell
entri
mainli
demonstr
phlebovirus
dengu
viru
west
nile
viru
addit
glycanbas
cell
surfac
interact
adv
bind
sever
proteinac
receptor
includ
coxsacki
adenoviru
receptor
car
integrin
scaveng
receptor
sr
fig
review
promin
protein
receptor
adv
car
transmembran
protein
belong
junction
adhes
molecul
jam
famili
within
immunoglobulin
ig
superfamili
car
consist
extracellular
domain
two
iglik
domain
transmembran
region
cytoplasm
tail
physiolog
function
car
promot
cellcel
adhes
form
homodim
iglik
domain
receptor
express
mani
organ
includ
brain
heart
lung
intestin
pancrea
liver
kidney
indic
car
possess
import
physiolog
role
sever
organ
vivo
car
first
identifi
receptor
coxsacki
b
virus
speci
c
serotyp
adv
subsequ
shown
play
role
attach
protein
speci
dg
adv
speci
b
adv
viru
side
knob
domain
viral
fiber
protein
mediat
bind
car
crystal
structur
adv
knob
domain
car
reveal
surfaceexpos
loop
knob
iglik
domain
car
form
highaffin
complex
fact
solubl
domain
car
alon
suffici
knob
bind
lead
inhibit
adv
infect
vitro
dilat
cardiomyopathi
patient
posit
correl
adv
load
car
express
observ
anoth
function
fibercar
interact
addit
cell
attach
promot
escap
newli
assembl
releas
virion
site
infect
achiev
product
releas
larg
excess
free
fiber
protein
advinfect
airway
epitheli
cell
free
fiber
protein
bind
intercellular
car
homodim
therebi
interrupt
cellcel
adhes
facilit
adv
escap
apic
surfac
integrin
cell
adhes
molecul
thatsimilar
carmedi
heterodimer
cellcel
interact
cell
adhes
molecul
interact
also
extracellular
matrix
compon
collagen
laminin
fibronectin
integrin
form
heterodim
subunit
vertebr
subunit
form
differ
known
heterodim
character
found
varieti
cell
cell
express
distinct
set
integrin
review
ref
rare
condit
integrin
serv
attach
factor
primarili
mediat
intern
membran
penetr
penton
base
interact
integrin
hematopoiet
cell
vitro
interact
mostli
mediat
conserv
argglyasp
rgd
motif
penton
base
protein
express
hadv
member
except
belong
speci
f
undergo
delay
uptak
epitheli
cell
mutat
rgd
motif
viru
penton
base
lead
delay
viru
reproduct
flat
adher
cell
integrin
includ
also
use
adv
coreceptor
integrin
promot
viru
intern
also
involv
membran
penetr
desmoglein
also
known
membran
cofactor
protein
mcp
express
nucleat
cell
belong
famili
regul
complement
activ
main
function
protect
uninfect
cell
complement
attack
consist
four
extracellular
short
consensu
repeat
scr
follow
serin
threonin
prolinerich
domain
stp
small
domain
unknown
function
transmembran
domain
cytoplasm
tail
speci
b
hadv
bind
car
shown
function
cellular
receptor
note
virus
includ
measl
viru
use
receptor
adv
mutat
analysi
infect
assay
demonstr
ntermin
src
domain
compris
adv
fiber
bind
site
addit
crystal
structur
fiber
knob
complex
src
domain
confirm
interact
reveal
bind
lead
conform
chang
moreov
surfac
express
downregul
earli
adv
infect
interact
adv
fiber
knob
sever
studi
show
function
cellular
receptor
speci
b
adv
except
vitro
contrast
sirena
et
al
report
serv
receptor
human
rodent
cell
line
trinh
et
al
demonstr
use
avid
depend
attach
increas
level
lead
enhanc
infect
speci
b
adv
use
main
receptor
protein
belong
cadherin
superfamili
identifi
main
receptor
unlik
interact
highaffin
bind
requir
penton
base
fiber
protein
sr
belong
larg
group
membranebound
receptor
classifi
accord
sequenc
famili
aj
first
sr
describ
goldstein
et
al
name
abil
bind
modifi
lowdens
lipoprotein
addit
lipoprotein
sr
also
recogn
ligand
proteoglycan
ferritin
carbohydr
cholesterol
ester
varieti
pathogen
advbas
vector
applic
sr
mediat
viru
uptak
accumul
liver
specif
liverresid
kupffer
cell
clear
advbas
vector
system
administr
interact
scaveng
receptor
sra
shown
respons
liver
uptak
mutat
analysi
adv
capsid
protein
vivo
administr
mice
reveal
sra
interact
mediat
hypervari
region
adv
hexon
protein
addit
piccolo
et
al
demonstr
helperdepend
adenovir
vector
interact
sra
sr
express
endotheli
cell
vitro
vivo
moreov
sr
marco
shown
facilit
adv
infect
murin
alveolar
macrophag
addit
aboveoutlin
receptor
interact
adv
also
describ
interact
vascular
cell
adhes
domain
major
histocompat
complex
mhci
express
cell
surfac
human
dendrit
cell
matur
b
lymphocyt
speci
b
adv
use
receptor
viru
knob
domain
requir
interact
like
car
belong
immunoglobulin
superfamili
consist
extracellular
domain
seven
iglik
domain
transmembran
region
cytoplasm
domain
main
function
act
endotheli
receptor
leukocyt
homolog
analysi
show
domain
domain
car
critic
adv
attach
signific
homolog
find
line
effici
advmedi
gene
transfer
express
cell
compar
cell
final
mhc
classi
molecul
broadli
express
nucleat
cell
act
receptor
domain
fiber
knob
bind
mhci
mhci
express
increas
suscept
taken
togeth
wide
rang
cellular
protein
receptor
adv
describ
speci
b
c
adv
instanc
car
function
receptor
adv
member
multipl
speci
other
rather
specif
given
vast
number
adv
speci
type
sever
asofyet
unknown
protein
receptor
like
exist
follow
paragraph
discuss
possibl
methodolog
advanc
may
aid
discoveri
current
orphan
adv
receptor
largescal
approach
studi
earli
virushost
cell
interact
glycan
array
shotgun
glycom
glycan
array
highthroughput
assay
allow
rapid
identif
protein
bind
glycan
fig
array
use
identifi
viru
attach
factor
receptor
determin
specif
virusglycan
interact
tabl
first
glycanbas
array
base
immobil
microbederiv
polysaccharid
nitrocelluloseco
glass
slide
altern
smaller
glycan
chemic
link
aminolipid
result
neoglycolipid
print
importantli
cluster
neoglycolipid
print
allow
analysi
low
affin
aviditydepend
interact
anoth
variat
immobil
cyclopentadieneconjug
monosaccharid
goldcoat
glass
slide
contain
benzoquinon
pentaethyleneglycol
group
differ
variant
print
array
use
examin
specif
broad
spectrum
glycanrecogn
antibodi
glycan
bind
protein
moreov
earli
work
laid
foundat
develop
stabl
glycan
array
increas
sensit
complex
glycan
array
compris
synthet
natur
glycan
defin
structur
develop
usbas
consortium
function
glycom
cfg
amino
group
derivat
glycan
print
aminoreact
nhydroxysuccinimid
glass
slide
proof
concept
studi
cfg
array
determin
bind
specif
variou
glycan
bind
protein
includ
galectin
antibodi
hemagglutinin
protein
influenza
viru
whole
virion
exampl
glycan
array
contain
limit
specif
type
glycan
includ
array
glycolipid
nglycan
oglycopeptid
gag
glycolipid
array
glycolipid
noncoval
print
polyvinyliden
difluorid
membran
could
determin
presenc
autoantibodi
human
serum
cerebrospin
fluid
gsl
interact
array
coval
immobil
gsl
nhydroxysuccinimideor
epoxideactiv
glass
array
slide
avail
mucin
oglycopeptid
array
could
identifi
glycopeptid
epitop
cancerspecif
antibodi
nglycanderiv
array
success
determin
glycanbind
specif
antihiv
antibodi
latter
case
enzymat
produc
nglycan
includ
highmannos
hybrid
complextyp
nlink
oligosaccharid
display
aluminiumoxideco
glass
slide
due
complex
heterogen
natur
develop
gagbas
array
hamper
howev
synthet
approach
recent
employ
gener
hsbase
glycan
librari
array
display
hsbase
oligosaccharid
reveal
specif
variou
hsbind
protein
limit
abovedescrib
glycan
librari
fulli
cover
glycan
divers
present
cell
tissu
solut
challeng
shotgun
glycom
sg
array
display
complex
celltissuederiv
glycan
fig
sg
technolog
demonstr
gsl
isol
human
erythrocyt
blood
type
prostat
cancer
cell
specif
chloroform
extract
gsl
tag
bifunct
fluoresc
molecul
n
aminoethyl
benzamid
aeab
aeab
contain
aryl
amin
allow
conjug
free
glycan
alkyl
amin
permit
conjug
reactiv
surfac
addit
fluoresc
tag
aeab
facilit
quantif
separ
conjug
gsl
exampl
whole
tissu
sg
pig
lung
glycoprotein
glycolipid
array
glycan
releas
nlink
glycoprotein
olink
glycoprotein
glycolipid
use
enzym
nonreduct
elimin
ozonolysi
respect
releas
glycan
fluoresc
tag
separ
hplc
coval
print
glass
slide
subsequ
probe
iav
glycan
array
develop
particular
cfg
imperi
colleg
london
icl
facilit
identif
sever
attach
factor
receptor
hadv
updat
cfgbase
array
contain
approxim
glycan
identifi
glycancontain
receptor
fig
b
specif
knob
bound
gangliosid
subsequ
cellbas
assay
structur
studi
confirm
specif
knob
glycan
differ
version
cfg
array
explor
bind
partner
speci
b
hadv
reveal
unlik
speci
use
sa
main
attach
factor
speci
b
use
hspg
lowaffin
attach
factor
final
cfg
array
demonstr
pandem
iav
interact
manner
correspond
tissu
host
tropism
virus
observ
support
previou
find
iav
specif
moreov
reliabl
glycan
array
icl
array
facilit
discoveri
sacontain
glycan
attach
molecul
note
share
unusu
featur
two
human
type
speci
f
adv
presenc
two
fiber
ssf
lsf
specif
ssf
interact
sa
structur
function
analysi
reveal
sa
interfac
side
trimer
short
fiber
knob
rather
central
caviti
case
despit
remark
knowledg
virusglycan
interact
gener
cfl
icl
glycan
array
sg
open
unpreced
opportun
identifi
glycancontain
viral
attach
factor
receptor
repres
convent
glycan
array
instanc
sg
identifi
possibl
endogen
glycan
attach
factor
receptor
iav
pig
lung
pig
lung
glycom
probe
sinc
iav
broadli
dissemin
swine
postul
intermediari
host
human
avian
iav
iav
mainli
interact
sacontain
nglycan
confirm
previou
result
recognit
iav
novel
endogen
nglycan
recognit
also
observ
final
sg
identifi
attach
factor
receptor
product
viru
infect
also
host
restrict
factor
decoy
receptor
instanc
sg
identifi
solubl
glycan
human
breast
milk
solubl
decoy
receptor
rotaviru
summari
glycan
arraybas
technolog
undergon
tremend
advanc
last
two
decad
enabl
discoveri
glycancontain
attach
factorsreceptor
speci
b
g
hadv
tabl
futur
technolog
may
use
uncov
addit
glycancontain
hadv
attach
factorsreceptor
addit
develop
glycan
array
technolog
field
virolog
past
decad
benefit
advanc
mass
spectrometrybas
proteom
particular
shotgun
proteom
unbias
detect
protein
given
biolog
sampl
hold
great
promis
identif
host
factor
viral
infect
basic
principl
shotgun
proteom
digest
protein
mixtur
defin
enzym
trypsin
subsequ
identif
protein
base
characterist
peptid
fingerprint
exampl
tryptic
peptid
uniqu
one
protein
whole
proteom
space
given
speci
improv
sensit
mass
spectrometri
recent
develop
labelfre
protein
quantif
method
collect
drive
applic
viru
receptor
discoveri
highlight
mass
spectrometrybas
proteom
identifi
adenoviru
attach
factor
receptor
past
give
outlook
technolog
aid
unravel
novel
receptor
futur
histor
viru
overlay
protein
bind
assay
vopba
first
success
use
mass
spectrometrybas
proteom
receptor
discoveri
vopba
resolv
cellular
protein
purifi
plasma
membran
protein
fraction
viru
suscept
cell
gel
electrophoresi
transfer
size
separ
cellular
protein
onto
membran
membran
probe
whole
viru
viru
attach
protein
vap
viru
surfac
structur
mediat
cell
attach
band
bound
viru
vap
visual
antibodi
correspond
band
duplic
protein
gel
final
subject
mass
spectrometri
fingerprint
identifi
put
receptor
vopba
success
identifi
lassa
viru
lymphocyt
choriomening
viru
receptor
alphadystroglycan
adv
receptor
latter
studi
hela
cell
membran
protein
separ
gel
electrophoresi
probe
fiber
knob
domain
previous
author
shown
fiber
knob
domain
compet
whole
viru
attach
author
confirm
interact
fiber
immunoprecipit
fiber
bind
protein
hela
cell
lysat
immunoblot
role
bona
fide
receptor
shown
bind
fluoresc
particl
competit
solubl
sirna
knockdown
subsequ
analysi
reveal
act
primari
receptor
speci
b
adv
other
use
low
affin
secondari
receptor
similar
vopba
approach
tri
identifi
cell
surfac
attach
factor
receptor
without
success
underlin
limit
vopba
approach
first
certain
attach
domain
may
destroy
denatur
condit
sdspage
second
interplay
sever
host
protein
receptor
complex
may
requir
viru
attach
higherord
protein
complex
destroy
gel
separ
third
affin
vap
fiber
knob
adenovirus
cognat
receptor
low
detect
use
vopba
approach
fact
virus
nonenvelop
envelop
profit
avid
effect
mediat
multipl
vap
per
particl
lastli
certain
carbohydr
interact
difficult
captur
vopba
glycosyl
receptor
interact
captur
vopba
shown
lassa
virusdystrogylcan
interact
hspg
interact
shown
strongli
depend
hspg
altern
receptor
fish
probe
use
vopba
approach
may
suitabl
addit
case
fiber
knob
alon
insuffici
mimic
bind
cellular
proteinac
receptor
elus
receptor
could
identifi
use
differ
vap
probe
name
recombin
penton
base
fiber
probe
effici
compet
whole
bind
suscept
cell
vopba
could
final
reveal
natur
receptor
bind
assay
includ
surfac
plasmon
reson
gain
loss
function
assay
fulli
infecti
confirm
receptor
interestingli
speci
b
adv
also
use
cellular
receptor
result
show
certain
serotyp
use
multipl
receptor
exampl
use
moreov
studi
underlin
critic
choic
vap
probe
receptor
fish
expedit
altern
vobpa
immunoadhesin
coimmunoprecipit
techniqu
receptor
bind
domain
vap
fuse
antibodi
fc
domain
immunoadhesin
captur
attach
factor
receptor
cell
surfac
cell
lysat
purifi
use
protein
ag
affin
resin
receptor
nipah
hendra
arenavirus
discov
use
immunoadhesin
despit
fact
receptor
captur
perform
liquid
state
use
physiolog
buffer
caveat
inadequ
choic
vap
probe
loss
avid
effect
still
appli
immunoadhesin
coimmunoprecipit
approach
new
shotgun
proteom
develop
may
overcom
limit
vopba
immunoadhesin
approach
major
advanc
achiev
introduct
quantif
method
shotgun
proteom
initi
reli
isotop
label
one
two
biolog
sampl
result
light
correspond
natur
isotop
heavi
option
medium
masslabel
protein
common
label
method
stabl
isotop
label
amino
acid
cell
cultur
silac
heavi
isotop
contain
lysin
arginin
fed
cell
cultur
nearli
protein
incorpor
isotopelabel
amino
acid
isotop
label
gener
characterist
mass
offset
label
protein
peptid
therefor
label
unlabel
sampl
could
process
measur
simultan
rel
abund
label
unlabel
peptid
quantit
compar
recent
labelfre
quantif
method
develop
allow
quantit
analysi
primari
cell
materi
tissu
without
chemic
label
reli
either
quantif
spectral
count
quantif
ion
intens
theori
method
combin
affin
enrich
hold
promis
purifi
virusreceptor
complex
cell
lysat
bind
intact
cell
detail
descript
affin
enrich
mass
spectrometri
aem
also
refer
immunoaffin
purif
coupl
mass
spectrometri
refer
reader
elsewher
aem
protein
interest
vap
purifi
togeth
bind
partner
bind
cell
surfac
either
antibodi
rais
endogen
vap
epitopetag
vap
use
copurifi
attach
factor
particular
use
whole
viru
approach
prove
valuabl
interact
depend
avid
effect
receptor
cluster
previous
aem
success
identifi
host
factor
interact
viral
nonstructur
protein
viru
famili
rang
flavivirus
herpesvirus
review
ref
applic
viru
receptor
discoveri
reach
fig
limit
aeip
receptor
discoveri
possibl
nonphysiolog
interact
may
occur
cell
lysi
breakdown
cellular
compartment
therefor
stabil
virusreceptor
complex
cell
lysi
aem
analysi
use
specif
crosslink
attract
strategi
crosslink
agent
design
ligandbas
receptor
captur
includ
compound
tricep
compris
three
function
group
specif
design
captur
glycosyl
receptor
extracellular
ligand
includ
virus
first
function
group
nh
ester
coupl
ligand
viru
particl
via
primari
amin
second
group
protect
aldehydereact
hydrazin
crosslink
glycosyl
receptor
third
function
group
biotin
purif
captur
receptor
use
streptavidin
resin
major
advantag
strategi
coval
crosslink
receptor
biotinyl
ligand
allow
digest
protein
tryptic
peptid
purif
avoid
loos
interact
partner
chosen
method
cell
lysi
tricep
shown
reliabl
identifi
receptor
insulin
transferrin
apelin
epiderm
growth
factor
therapeut
antibodi
trastuzumab
importantli
attach
factor
vaccinia
viru
axl
well
receptor
growth
factor
nerv
bind
peptid
identifi
use
trifunct
crosslink
discoveri
axl
bind
phosphytidylserin
viral
envelop
highlight
crosslink
approach
potenti
identifi
proteinprotein
interact
also
proxim
lipidprotein
interact
similar
compound
aldehydereact
aminooxi
group
sulfhydryl
group
biotin
group
contain
compound
asb
recent
describ
use
identifi
receptor
peptid
hormon
monoclon
antibodi
combin
biocompat
ligand
captur
method
shotgun
proteom
like
allow
fast
effici
identif
viru
receptor
futur
fig
apart
captur
primari
interact
physiolog
condit
shotgun
proteom
potenti
map
whole
network
protein
specif
host
protein
interact
network
viru
receptor
absenc
presenc
bound
viru
delin
receptor
signal
host
proteinprotein
interact
critic
guid
product
viru
uptak
unravel
higherord
receptor
complex
help
understand
viru
host
cell
invas
upon
viru
bind
receptor
intracellular
protein
network
may
chang
alter
may
trigger
viru
uptak
cluster
viru
receptor
recruit
accessori
factor
context
welldescrib
phenomenon
clearli
knowledg
receptor
accessori
protein
chang
protein
network
viru
entri
help
better
understand
molecular
detail
viru
invas
aspect
viru
entri
yet
address
shotgun
proteom
usag
secondari
intracellular
receptor
past
decad
becam
evid
virus
requir
cell
surfac
receptor
also
endosom
receptor
particular
ebola
viru
lassa
viru
shown
undergo
receptor
switch
endocytosi
switch
critic
trigger
membran
fusion
henc
proteom
approach
futur
resolv
spatiotempor
interact
viru
entri
solut
problem
may
use
proxim
label
method
protein
express
distinct
subcellular
compart
fuse
enzym
coval
link
biotin
anoth
probe
protein
close
proxim
review
ref
label
allow
twostep
purif
protocol
enrich
organel
specif
protein
subsequ
immunoprecipit
bait
vap
feasibl
spatiotempor
resolut
protein
network
recent
demonstr
gproteincoupl
receptor
similar
approach
like
prove
valuabl
secondari
viru
entri
receptor
discoveri
map
spatiotempor
chang
host
cell
protein
network
induc
viru
penetr
taken
togeth
mass
spectrometrybas
proteom
undergon
massiv
technolog
advanc
enabl
principl
discov
virusprotein
interact
cell
surfac
intracellular
compart
date
approach
tailor
viru
recombin
fiber
knob
penton
base
fiber
prove
suitabl
receptor
fish
futur
studi
reveal
novel
probe
use
adenoviru
type
discov
proteinac
cellular
receptor
unquestion
glycom
proteom
two
sever
technolog
virologist
toolbox
discov
host
factor
includ
viru
receptor
power
method
use
combin
glycom
proteom
includ
rna
interfer
knockout
genomewid
haploid
screen
cellbas
array
drugbas
approach
util
microarraycharacter
set
cell
provid
us
nation
cancer
institut
refer
reader
elsewher
inform
method
clear
advantag
labelfre
glycom
proteom
technolog
howev
minim
system
perturb
particular
untag
endogen
bait
glycan
protein
use
contrast
genet
drug
base
approach
alter
biolog
system
either
silencingknock
gene
interest
block
biolog
function
small
molecul
essenti
protein
may
lead
cytotox
compensatori
effect
upregul
cellular
pathway
replac
function
knock
inhibit
pathway
moreov
mani
virus
promiscu
use
secondari
entri
pathway
absenc
primari
entri
pathway
notabl
phenomenon
independ
compensatori
cellular
mechan
question
suitabl
singlemolecul
knockoutinhibit
screen
promiscu
virus
altern
entri
pathway
usag
clearli
shown
iav
use
either
clathrindepend
independ
uptak
rout
depend
avail
notion
versatil
viru
entri
strategi
support
fact
iav
rna
interfer
screen
reveal
differ
host
factor
hit
depend
assay
setup
target
cell
use
thu
glycom
proteom
approach
seem
particularli
use
analyz
physiolog
contribut
viru
entri
pathway
unbias
manner
anoth
benefit
labelfre
glycom
proteom
possibl
analyz
primari
cell
tissu
materi
contrast
haploid
screen
perform
specif
develop
cell
line
may
product
infect
certain
virus
crispr
knockout
turn
rare
amen
primari
cell
often
rapidli
lose
differenti
state
ex
vivo
clearli
rna
interfer
indispens
followup
analysi
valid
glycom
proteom
hit
obvious
mere
interact
vap
host
protein
provid
inform
function
interact
factor
entri
process
downstream
analysi
use
one
sever
mention
genet
pharmacolog
method
critic
requir
distinguish
attach
factor
receptor
accessori
molecul
cytotox
compensatori
mechan
gene
knockout
caveat
followup
rna
interfer
therefor
still
import
altern
method
care
control
taken
togeth
smart
combin
glycanand
proteinbas
screen
technolog
togeth
genet
drugbas
valid
method
draw
clear
pictur
viru
invas
strategi
underli
cell
biolog
process
system
biolog
view
viru
entri
like
impact
drug
develop
person
medicin
research
identif
receptor
rare
simpl
straightforward
outcom
effort
usual
facilit
substanti
preexist
knowledg
natur
receptor
guid
strategi
use
despit
technolog
advanc
glycom
proteom
number
bottleneck
need
overcom
allow
usag
technolog
viru
entri
factor
discoveri
broad
fashion
viruscel
interact
seldom
binari
singl
step
process
mani
virus
includ
adv
appear
use
molecul
receptor
poorli
express
apic
side
polar
differenti
epitheli
target
cell
therefor
access
initi
specif
molecul
cellular
junction
basolater
side
cell
includ
jam
nectin
car
icam
integrin
use
entri
port
cell
exampl
jama
usag
reovirus
occludin
usag
hepat
c
viru
car
usag
coxsackieviru
adv
overcom
problem
limit
receptor
access
virus
develop
strategi
disrupt
tight
junction
use
altern
receptor
transcytos
epithelia
via
cell
induc
target
transfer
receptor
tight
junction
adv
infect
certain
adhes
molecul
appear
reloc
apic
surfac
respons
antivir
cytokin
reloc
adhes
molecul
tether
neutrophil
enhanc
initi
infect
intact
epithelium
altern
certain
splice
variant
adhes
molecul
found
apic
surfac
coxsackieviru
b
seem
conundrum
junction
molecul
usag
entri
receptor
solv
semin
studi
coyn
bergelson
demonstr
coxsackieviru
b
initi
interact
gpianchor
protein
decayacceler
factor
apic
surfac
cell
activ
abl
kinas
trigger
racdepend
actin
rearrang
lead
viru
transloc
tight
junction
junction
coxsackieviru
b
interact
car
induc
conform
chang
viral
capsid
cell
entri
captur
late
interact
requir
synchron
infect
ideal
possibl
arrest
entri
site
late
entri
factor
engag
challeng
exist
character
interact
endosom
compart
synchron
apic
bind
achiev
cool
cell
therebi
arrest
traffick
block
entri
subsequ
step
trivial
requir
knowledg
exact
entri
pathway
suscept
drug
may
specif
block
viru
uptak
arrest
virus
earli
endosom
compart
one
possibl
despit
enhanc
throughput
proteom
glycom
method
viru
entri
research
current
lack
highthroughput
techniqu
address
one
question
time
exampl
impact
plasmamembran
receptor
vesiclebas
transport
solubl
extracellular
host
factor
microb
bottleneck
may
overcom
combin
apex
method
label
subcellular
compart
describ
regard
impact
extracellular
factor
complement
factor
solubl
decoy
receptor
extracellular
matrix
molecul
recent
effort
demonstr
usag
labelfre
ms
identif
quantif
protein
biolog
fluid
includ
cellular
secret
meissner
colleagu
could
detect
thousand
secret
protein
concentr
rang
span
order
magnitud
discov
novel
secretori
protein
yet
unknown
function
expect
numer
biolog
signific
viru
interact
secretori
protein
extracellular
glycan
shape
viru
infect
interact
proteom
studi
virus
secretori
fluid
feasibl
address
physiolog
function
secretori
interactor
requir
complex
tissu
cultur
model
exampl
organoid
cultur
term
throughput
proteom
analysi
becom
compat
critic
establish
highthroughput
compat
viru
entri
proteom
glycom
pipelin
would
allow
research
assess
sever
cell
type
viru
serotyp
time
draw
differenti
pictur
adv
entri
host
cell
clear
bottleneck
establish
compat
affin
enrich
method
major
challeng
adenoviru
field
lack
small
anim
model
adenovirus
multipl
speci
speci
c
adv
replic
high
titer
mimic
tropism
pathogenesi
exampl
ekccaus
adv
absenc
model
difficult
predictselect
main
target
cell
adv
replic
vivo
therebi
risk
cell
use
attempt
identifi
novel
receptor
correspond
true
target
cell
thu
express
correct
receptorcoreceptor
combin
absenc
human
glycom
atla
major
limit
establish
glycan
array
repres
small
fraction
human
glycom
hitherto
glycan
librari
synthes
chemic
enzymat
gener
purif
biolog
sourc
howev
recent
progress
gener
glycan
librari
natur
sourc
use
enzym
hydrazinolysi
andor
oxidationbas
approach
open
possibl
develop
array
comprehens
coverag
glycan
inon
specif
cell
tissu
challeng
separ
larg
number
differ
glycan
similarident
molecular
weight
glycan
differ
molecular
weight
howev
purifi
character
hplc
matrixassist
laser
desorptionionizationtim
flight
spectroscopi
respect
regardless
glycan
librari
size
anoth
limit
glycan
array
fulli
mimic
physiolog
environ
respect
membranemedi
mobil
local
fluidic
environ
proxim
cell
tissu
current
method
requir
label
antibodybas
detect
discuss
addit
challeng
bottleneck
describ
recent
discoveri
provid
novel
insight
also
complex
understand
viru
attach
entri
target
cell
among
discoveri
abil
hepat
viru
packag
cluster
within
phosphatidylserin
lipidenrich
vesicl
releas
cell
nonlyt
manner
envelop
form
typic
nonenvelop
virus
display
increas
infect
effici
compar
nonenvelop
viral
particl
use
altern
entri
receptor
anoth
recent
discoveri
challeng
previou
dogma
enter
virus
reli
microb
stabilitysurviv
potenti
also
attach
entri
target
cell
describ
futur
research
also
consid
even
solubl
host
molecul
blood
factor
lactoferrin
affect
attach
entri
mechan
moreov
virus
ebola
lassa
viru
requir
receptor
switch
intracellular
compart
thu
use
cell
surfac
receptor
also
secondari
endosom
receptor
taken
togeth
challeng
design
perform
largescal
approach
fulli
mimic
vivo
situat
given
viru
aim
identifi
specif
host
molecul
essenti
viru
attach
entri
research
need
design
develop
experiment
approach
case
case
basi
consid
sum
prior
knowledg
structur
biochemistri
tropism
given
viru
